| Dr Thomas Paul Mezzetti Jr, MD | |
|
5301 Virginia Way, Suite 300, Brentwood, TN 37027-7541 | |
| (615) 695-4977 | |
| (615) 263-3348 |
| Full Name | Dr Thomas Paul Mezzetti Jr |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 32 Years |
| Location | 5301 Virginia Way, Brentwood, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083668453 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charlotte Hungerford Hospital | Torrington, CT | Hospital |
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Pathology Associates Pc | 8729989561 | 34 |
News Archive
Patients with non-alcoholic fatty liver disease who participated in a web-based lifestyle modification intervention achieved similar levels of weight loss and more rapid normalization of their liver enzymes than patients who participated in an intensive, group-based program.
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen).
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.
When laboratory mice were modeled with colitis and treated with human umbilical cord-derived mesenchymal cells, the cells homed in on the inflamed colon and effectively ameliorated colitis, reported a study published in a recent issue of Cell Transplantation.
"This morning on ABC News' 'This Week,' Senior White House Advisor David Axelrod insisted that President Obama's recess appointment of Dr. Donald Berwick to be the administrator of The Centers for Medicare and Medicaid Services was simply 'too important' to wait for a Congressional hearing" (7/11).
› Verified 9 days ago
| Entity Name | Hartford Pathology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063464477 PECOS PAC ID: 8729989561 Enrollment ID: O20040115000745 |
News Archive
Patients with non-alcoholic fatty liver disease who participated in a web-based lifestyle modification intervention achieved similar levels of weight loss and more rapid normalization of their liver enzymes than patients who participated in an intensive, group-based program.
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen).
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.
When laboratory mice were modeled with colitis and treated with human umbilical cord-derived mesenchymal cells, the cells homed in on the inflamed colon and effectively ameliorated colitis, reported a study published in a recent issue of Cell Transplantation.
"This morning on ABC News' 'This Week,' Senior White House Advisor David Axelrod insisted that President Obama's recess appointment of Dr. Donald Berwick to be the administrator of The Centers for Medicare and Medicaid Services was simply 'too important' to wait for a Congressional hearing" (7/11).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Paul Mezzetti Jr, MD 5301 Virginia Way, Suite 300, Brentwood, TN 37027-7541 Ph: (615) 695-4977 | Dr Thomas Paul Mezzetti Jr, MD 5301 Virginia Way, Suite 300, Brentwood, TN 37027-7541 Ph: (615) 695-4977 |
News Archive
Patients with non-alcoholic fatty liver disease who participated in a web-based lifestyle modification intervention achieved similar levels of weight loss and more rapid normalization of their liver enzymes than patients who participated in an intensive, group-based program.
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen).
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type 2 diabetes. A new fingerprint of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes has been identified by Boston University School of Medicine researchers.
When laboratory mice were modeled with colitis and treated with human umbilical cord-derived mesenchymal cells, the cells homed in on the inflamed colon and effectively ameliorated colitis, reported a study published in a recent issue of Cell Transplantation.
"This morning on ABC News' 'This Week,' Senior White House Advisor David Axelrod insisted that President Obama's recess appointment of Dr. Donald Berwick to be the administrator of The Centers for Medicare and Medicaid Services was simply 'too important' to wait for a Congressional hearing" (7/11).
› Verified 9 days ago
Kathy Bruner, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Kenneth S Piech, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Roy W. Kirchberg Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Dr. Lori D Emerson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-695-4977 | |
Ben W Davis, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Randall L Woodford, MD Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Dr. Soheila Yadrandji, MD Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 |